NCT04636359

Brief Summary

This study recruits 30 subjects into three groups, including two experimental groups and one control group. The two experimental groups receive acupuncture treatment for 4 weeks and two times functional magnetic resonance imaging scans as well as clinical symptom assessments. The control group receive one scan without any intervention. The aim of this study is to find the whether the effect of acupuncture treatment have diversity among migraineurs with different disease course.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 30, 2017

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2019

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2020

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

November 4, 2020

Completed
15 days until next milestone

First Posted

Study publicly available on registry

November 19, 2020

Completed
Last Updated

November 20, 2020

Status Verified

November 1, 2020

Enrollment Period

2.2 years

First QC Date

November 4, 2020

Last Update Submit

November 19, 2020

Conditions

Keywords

AcupunctureFunctional magnetic resonance imaging

Outcome Measures

Primary Outcomes (4)

  • Headache Intensity

    The headache intensity is measured by the value of Visual Analogue Scale which limits 1 to 10. The higher value of this scale represents the worse headache.

    Change from Visual Analogue Scale at 1 months.

  • Headache Days

    The days when headache attacked. The increased day represents the worse headache.

    Change from the number of day at 1 months.

  • Headache Frequency

    The maximum times in one day during the headache attacked. The increased time represents the worse headache.

    Change from the times of headache attack at 1 months.

  • Dataset of functional magnetic resonance imaging on brain

    Dataset of functional magnetic resonance imaging on brain includes functional images, structural images and diffusion tensor images.

    Changes from the dataset of subject's brain area at 1 months.

Secondary Outcomes (2)

  • Pittsburgh Sleep Quality Index

    Change from the value of Pittsburgh Sleep Quality Index at 1 months.

  • Medical Outcomes Study Short-Form 36 questionnaire

    Change from the value of Medical Outcomes Study Short-Form 36 questionnaire at 1 months.

Study Arms (2)

Long term course of migraine patient without aura

EXPERIMENTAL

Patients in this group have the history of migraine without aura more than 5 years.

Behavioral: Acupuncture stimulation

Short term course of migraine patient without aura

EXPERIMENTAL

Patients in this group have the history of migraine without aura equal or less than 5 years.

Behavioral: Acupuncture stimulation

Interventions

The intervention is about acupuncture treatment, which has 4 weeks acupoint stimulation and the frequency is 30 minutes each times for 3 times per week. The acupoints include SJ23 (Si Zhu Kong, unilateral), GB8 (Shuai Gu, unilateral), EX-HN5 (Tai Yang, unilateral), GB20 (Feng Chi, unilateral), LI4 (He Gu, bilateral), GB41 (Zu Lin Qi, bilateral), GB34 (Yang Ling Quan, bilateral) and SJ5 (Wai Guan, bilateral).

Long term course of migraine patient without auraShort term course of migraine patient without aura

Eligibility Criteria

Age18 Years - 55 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Fitting to the standard of migraine without aura in the international classification of headache disease (ICHD-2) issued by the international headache society in 2004.
  • Age from 18 to 55, male or female, with right-handedness.
  • Having no depression or other serious mental illness.
  • Having no psychoactive drugs taken in the past 3 months, or vasoactive drugs in the past 2 weeks.
  • Having no habit of taking analgesics from a long time.

You may not qualify if:

  • Having the first headache attack of migraine after 55 years old.
  • Having a history of head injury, cluster headache, or other unclassified headaches.
  • Taking medicine to prevent migraine in recent 4 weeks.
  • Having the serious asymmetry or definite pathological changes in the anatomical structure of the head through the MRI scan.
  • Cannot hold on the times of the MRI scan.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dongzhimen Hospital

Beijing, 100007, China

Location

MeSH Terms

Conditions

Migraine without Aura

Condition Hierarchy (Ancestors)

Migraine DisordersHeadache Disorders, PrimaryHeadache DisordersBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Officials

  • Yi Ren, Doctor

    Dongzhimen Hospital, Beijing

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Model Details: Two experimental groups with different condition receive identical intervention, with control group as baseline for comparison.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Deputy director of Neurology

Study Record Dates

First Submitted

November 4, 2020

First Posted

November 19, 2020

Study Start

October 30, 2017

Primary Completion

December 30, 2019

Study Completion

February 1, 2020

Last Updated

November 20, 2020

Record last verified: 2020-11

Data Sharing

IPD Sharing
Will not share

The data of this study includes two aspect, data of brain scans and data of clinical symptom scales. The latter data will be shared to other researchers who contact us via email. The former data, however, is a DICOM format data that hard to analysis in non specialists. Besides, the size of DICOM data is much big that we haven't enough funding to support it in website. Thus, we haven't decided to share this kind of dataset. Except for those data, other data within our study is willing to be share. Our email: clancy\_wu@bucm.edu.cn; clancy\_wu@126.com; clancy.wu94@gmail.com.

Locations